Department of Psychiatry, Wright State University Boonshoft School of Medicine, Fairborn (Dr Gainer, Dr Nahhas, Dr Bhatt, Ms Merrill, Ms McCormack); Department of Population & Public Health Sciences, Wright State University Boonshoft School of Medicine, Kettering (Dr Nahhas), Ohio.
J Occup Environ Med. 2021 Feb 1;63(2):89-97. doi: 10.1097/JOM.0000000000002086.
The primary objective of this cross-sectional study was to examine the association between time spent treating patients with Coronavirus disease 2019 (COVID-19) and levels of depression, anxiety, and posttraumatic stress disorder (PTSD) in US physicians.
The authors conducted an anonymous online survey of US physicians. Linear regression was used to test the association between proportion of day treating COVID-19 and symptoms of depression, anxiety, and PTSD.
In a sample of 1724 US physicians, proportion of day treating COVID-19 was positively and significantly associated with depression, anxiety, and PTSD scores (P < 0.001 for each).
Mental health resources should be provided to physicians who treat COVID-19 because the proportion of day treating COVID-19 is associated with depression, anxiety, and PTSD outcomes.
本横断面研究的主要目的是检验美国医生治疗 2019 年冠状病毒病(COVID-19)患者的时间与抑郁、焦虑和创伤后应激障碍(PTSD)水平之间的关系。
作者对美国医生进行了匿名在线调查。线性回归用于检验治疗 COVID-19 的天数与抑郁、焦虑和 PTSD 症状之间的关联。
在 1724 名美国医生的样本中,治疗 COVID-19 的天数与抑郁、焦虑和 PTSD 评分呈正相关且具有统计学意义(每项 P < 0.001)。
应向治疗 COVID-19 的医生提供心理健康资源,因为治疗 COVID-19 的天数与抑郁、焦虑和 PTSD 结果相关。